These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 2360251)
1. Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man. Lazda VA; Pollak R; Mozes MF; Barber PL; Jonasson O Transplantation; 1990 Jun; 49(6):1084-7. PubMed ID: 2360251 [TBL] [Abstract][Full Text] [Related]
2. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival. Kerman RH; Kimball PM; Lindholm A; Van Buren CT; Katz SM; Lewis RM; McClain J; Podbielski J; Williams J; Kahan BD Transplantation; 1993 Nov; 56(5):1242-7. PubMed ID: 8249130 [TBL] [Abstract][Full Text] [Related]
3. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine. Cheigh JS; Suthanthiran M; Fotino M; Riggio RR; Schechter N; Stubenbord WT; Stenzel KH; Rubin AL Transplantation; 1991 Feb; 51(2):378-81. PubMed ID: 1825244 [TBL] [Abstract][Full Text] [Related]
4. The effect of mismatching for HLA-DR in recipients of renal allografts sharing one HLA-ABC haplotype with related donors. Sutherland DE; Morrow CE; Kaufman D; Fryd DS; Najarian JS; Burke M; Noreen H; Segall M; Bach FH Transplantation; 1983 Dec; 36(6):643-7. PubMed ID: 6362140 [TBL] [Abstract][Full Text] [Related]
9. Role of preoperative donor-specific transfusion and cyclosporine in haplo-identical living related renal transplant recipients. Sharma RK; Rai PK; Kumar A; Kumar P; Gupta A; Kher V; Agrawal S; Bhandari M Nephron; 1997; 75(1):20-4. PubMed ID: 9031265 [TBL] [Abstract][Full Text] [Related]
10. Influence of HLA disparity, immunosuppressive regimen used, and type of kidney allograft on production of anti-HLA class-I antibodies after transplant and occurrence of rejection. Abdelnoor AM; Ajib R; Chakhtoura M; Daouk M; Medawar W; Uwaydah M; Sawah SI; Khauli RB Immunopharmacol Immunotoxicol; 2009; 31(1):83-7. PubMed ID: 18752168 [TBL] [Abstract][Full Text] [Related]
11. HLA-A antigen incompatibility and HLA-B antigen compatibility associated with enhanced kidney allograft survival in blood-transfused patients. Bućin D Exp Clin Immunogenet; 1986; 3(3):138-44. PubMed ID: 3274633 [TBL] [Abstract][Full Text] [Related]
12. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
13. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine. Kerman RH; van Buren CT; Lewis RM; Frazier OH; Cooley D; Kahan BD Transplantation; 1988 Feb; 45(2):333-7. PubMed ID: 3278425 [TBL] [Abstract][Full Text] [Related]
14. HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome. Christiaans MH; van Hooff JP; Nieman F; van den Berg-Loonen EM Transplantation; 1999 Apr; 67(7):1029-35. PubMed ID: 10221489 [TBL] [Abstract][Full Text] [Related]
15. The changing role of HLA matching. Cecka JM Clin Transpl; 1986; ():141-55. PubMed ID: 3154392 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group. Alexander JW; Light JA; Donaldson LA; Delmonico FL; Diethelm AG; Wilkinson A; Rosenthal JT; Thistlethwaite JR; Hunsicker LG; Matas AJ; First MR; Reinsmoen NL; Rose SM Transplantation; 1999 Oct; 68(8):1117-24. PubMed ID: 10551639 [TBL] [Abstract][Full Text] [Related]
18. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094 [TBL] [Abstract][Full Text] [Related]
19. The effect of HLA-A, -B matching on cadaver renal allograft rejection comparing public and private specificities. Sanfilippo F; Vaughn WK; Spees EK; Heise ER; LeFor WM Transplantation; 1984 Nov; 38(5):483-9. PubMed ID: 6388069 [TBL] [Abstract][Full Text] [Related]
20. Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept. Doxiadis II; Smits JM; Schreuder GM; Persijn GG; van Houwelingen HC; van Rood JJ; Claas FH Lancet; 1996 Sep; 348(9031):850-3. PubMed ID: 8826810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]